Abeona Therapeutics (ABEO) Other Non-Current Assets (2010 - 2026)

Abeona Therapeutics' Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $827000.0 for Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 1350.88% year-over-year to $827000.0; the TTM figure through Mar 2026 stood at $827000.0 (up 1350.88% YoY), while the FY2025 annual figure was $781000.0, up 713.54% from the prior year.
• Other Non-Current Assets was $827000.0 for Q1 2026 at Abeona Therapeutics, up from $781000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $5.9 million in Q1 2022 to a low of $57000.0 in Q1 2025.
• Historically, Other Non-Current Assets has averaged $1.3 million across 5 years, with a median of $338000.0 in 2022.
• The sharpest annual moves came in 2022 and 2026: Other Non-Current Assets plunged 94.26% in 2022, then surged 1350.88% in 2026.
• A 5-year view of Other Non-Current Assets shows it stood at $338000.0 in 2022, then changed by 0.0% to $338000.0 in 2023, then tumbled by 71.6% to $96000.0 in 2024, then soared by 713.54% to $781000.0 in 2025, then increased by 5.89% to $827000.0 in 2026.
• The last three Other Non-Current Assets figures came in at $827000.0 (Q1 2026), $781000.0 (Q4 2025), and $541000.0 (Q3 2025), per Business Quant data.